Published May 25, 2023
| Version v1
Journal article
Open
Antibody Characterization Report for Leucine-rich repeat kinase 2 (LRRK2)
Creators
- 1. Montreal Neurological Institute
- 2. Advanced BioImaging Facility (ABIF), McGill University
Description
Head-to-head comparison of available commercial antibodies against Leucine-rich repeat kinase 2 (LRRK2) by immunoblot (Western blot), immunoprecipitation and immunofluorescence. Work reported in this report was supported in part by the Michael J. Fox Foundation for Parkinson's research.
Files
Leucine-rich repeat kinase 2_LRRK2_YCharOS report.pdf
Files
(7.7 MB)
Name | Size | Download all |
---|---|---|
md5:e790c3bd89682c0d4d45ea468dfe82a8
|
7.7 MB | Preview Download |